Can PSMA PET/CT help in dose-tailoring in post-prostatectomy radiotherapy?

Champion, Ambroise; Zwhalen, Daniel Rudolf; Oehler, Christoph; Taussky, Daniel; Kroeze, Stephanie G C; Burger, Irene A; Benzaquen, David

Champion, Ambroise; Zwhalen, Daniel Rudolf; Oehler, Christoph; Taussky, Daniel; Kroeze, Stephanie G C; Burger, Irene A; Benzaquen, David.

Afiliación

Champion A; Radiation Oncology, Hôpital de La Tour, Meyrin, Switzerland.
Zwhalen DR; Department of Radiation Oncology, Kantonsspital Winterthur, Winterthur, Switzerland.
Oehler C; Department of Radiation Oncology, Kantonsspital Winterthur, Winterthur, Switzerland.
Taussky D; Radiation Oncology, Hôpital de La Tour, Meyrin, Switzerland.
Kroeze SGC; Department of Radiation Oncology, Centre Hospitalier de l'Université de Montréal, Montréal, QC, Canada.
Burger IA; Department of Radiation Oncology Kantonsspital Aarau and Baden, Kantonsspital Aarau, Aarau, Switzerland.
Benzaquen D; Department of Nuclear Medicine, Kantonsspital Baden, Baden, Switzerland.

Front Oncol ; 13: 1268309, 2023.

Article en En | MEDLINE | ID: mdl-37799463

Palabras clave

PSA; PSMA-PET; dose ecalation; postoperative radiotherapy; prostate cancer

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Clinical_trials / Observational_studies Idioma: En Revista: Front Oncol Año: 2023 Tipo del documento: Article País de afiliación: Suiza

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google